Kaspofungin Pliva 50 mg prašak za koncentrat za otopinu za infuziju
| Name | Kaspofungin Pliva 50 mg prašak za koncentrat za otopinu za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-865026781 |
| Active Substance | kaspofunginacetat |
| Composition | jedna bočica sadrži 50 mg kaspofungina (u obliku kaspofunginacetata) |
| Pharmaceutical Form | prašak za koncentrat za otopinu za infuziju |
| Manufacturer | Pharmathen S.A., Pallini Attiki, Grčka Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Teva Pharma B.V., Haarlem, Nizozemska Pharmadox Healthcare Limited, Paola PLA, Malta Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 08.03.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/25 |
| Registration Number | 381-12-01/154-22-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J02AX04 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o potrebi izbjegavanja primjene poliakrilonitrilskih membrana tijekom kontinuirane bubrežne nadomjesne terapije u bolesnika na terapiji lijekovima koji sadrže kaspofungin | 09.10.2025 | PharmaS d.o.o., Pliva Hrvatska d.o.o., Zentiva, k.s, Ligula Pharma d.o.o., Rhei Life d.o.o./Marti Farm d.o.o. |
